Dr. Tomasz Sablinski is the Head of Clinical Development and a member of the Executive Committee of Celtic Therapeutics Development (CTD). Dr. Sablinski joined CTD with twenty eight years of experience in healthcare, including his last fifteen years in the global pharmaceutical industry. His career includes ten years of clinical practice as a surgeon specializing in renal transplantation and general surgery, and several years of basic research in immunobiology.
Prior to joining CTD, Dr. Sablinski served as Vice President at Novartis Pharmaceuticals Corp. in charge of US Clinical Development and Medical Affairs. Prior to this, Dr. Sablinski held several leadership positions at Novartis headquarters including Vice President of Clinical Research and Development and Head of Global-Japanese Coordination. He also held multiple leadership positions in Novartis’ Transplantation Business Unit. He participated in, and supervised numerous NDA and IND submissions in the US, Europe and Japan. Dr. Sablinski earned his MD and his Ph.D. in transplant immunology at Warsaw Medical School and his bachelor degrees at Copernicus College in Warsaw, Poland.